Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Loose Anagen Syndrome causes easy-to-pull, thin hair, mainly in young girls, and improves with age.

Wnt1a helps keep cells that can grow hair effective for potential hair loss treatments.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

A gene mutation in mice causes permanent hair loss and skin issues.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Lasers, microneedling, and PRP improve skin rejuvenation and repair, with PRP enhancing the effects when combined with other treatments.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Sorafenib after liver surgery may increase survival for some liver cancer patients.